Thyroid dysfunction and anemia in a large population-based study.

M'rabet Bensalah, Khadija; Aubert, Carole E; Coslovsky, Michael; Collet, Tinh-Hai; Baumgartner, Christine; den Elzen, Wendy P J; Luben, Robert; Angelillo-Scherrer, Anne; Aujesky, Drahomir; Khaw, Kay-Tee; Rodondi, Nicolas (2016). Thyroid dysfunction and anemia in a large population-based study. Clinical endocrinology, 84(4), pp. 627-631. Blackwell Scientific Publications 10.1111/cen.12994

	Text M'Rabet-Bensalah ClinEndocrinol(Oxf) 2016.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (95kB) | Request a copy
Preview	Text M'Rabet-Bensalah ClinEndocrinol 2016_AAM.pdf - Accepted Version Available under License Publisher holds Copyright. Download (208kB) | Preview

OBJECTIVE AND BACKGROUND

Anemia and thyroid dysfunction are common and often co-occur. Current guidelines recommend the assessment of thyroid function in the work-up of anemia, although evidence on this association is scarce.

PATIENTS AND METHODS

In the "European Prospective Investigation of Cancer" (EPIC)-Norfolk population-based cohort, we aimed to examine the prevalence and type of anemia (defined as hemoglobin <13 g/dl for men and <12 g/dl for women) according to different thyroid function groups.

RESULTS

The mean age of the 8791 participants was 59.4 (SD 9.1) years and 55.2% were women. Thyroid dysfunction was present in 437 (5.0%) and anemia in 517 (5.9%) participants. After excluding 121 participants with three most common causes of anemia (chronic kidney disease, inflammation, iron deficiency), anemia was found in 4.7% of euthyroid participants. Compared with the euthyroid group, the prevalence of anemia was significantly higher in overt hyperthyroidism (14.6%, P < .01), higher with borderline significance in overt hypothyroidism (7.7%, P = .05) and not increased in subclinical thyroid dysfunction (5.0% in subclinical hypothyroidism, 3.3% in subclinical hyperthyroidism). Anemia associated with thyroid dysfunction was mainly normocytic (94.0%), and rarely macrocytic (6.0%).

CONCLUSION

The prevalence of anemia was higher in overt hyperthyroidism, but not increased in subclinical thyroid dysfunction. Systematic measurement of thyroid-stimulating hormone in anemic patients is likely to be useful only after excluding common causes of anemia.

Interest & Impact

Downloads

163 since deposited on 23 Feb 2016
50 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item